Intellectual Property India Publishes Patent Application for 'Emopamil-Binding Protein Inhibitors And Uses Thereof' Filed by Biogen Ma Inc.

MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517008670 A) filed by Biogen Ma Inc., Cambridge, U.S.A., on Feb. 3, for 'emopamil-binding protein inhibitors and uses thereof.'

Inventor(s) include Lopez De Turiso, Felix, Gonzalez; Himmelbauer, Martin; Jones, John, H.; Lin, Edward, Yin Shiang; Prince, Robin; Pattaropong, Vatee; and Xin, Zhili.

The application for the patent was published on May 9, under issue no. 19/2025.

According to the abstract released by the Intellectual Property India: "Provided are compounds of the Formula (I) or pharmaceutically acceptable salts thereof, which are useful for the inhibition of EBP and in the treatment of a variety of EBP mediated conditions or diseases, suc...